Advocacy News

This session described successful strategies for a streamlined revenue cycle, including how to pivot from a high-level dashboard report to targeted data elements that can prompt actionable steps to avoid revenue cycle catastrophes.

This session harnessed our community's collective energy and dedication towards creating a more sustainable future in ophthalmology.

This session provided residents and fellowship trainees an opportunity to network and interact with leaders in ophthalmology and with other trainees around the country with panel discussions covering four major areas: Leadership, Engagement, Advocacy, and Practice Management.

This session examined the positives and negatives of private equity and the impact that it may have on an Academy member’s ability to speak publicly in support of Academy legislative and/or regulatory priorities, as well as potentially inadvertent violations of the Academy’s Code of Ethics.

We’re supporting physician candidates in several congressional races, including two with military service.

On May 1, both the Senate Committee on Finance and House Energy and Commerce Oversight and Investigations Subcommittee held hearings in which they demanded answers from the UnitedHealth Group CEO on what caused the Feb. 21 cyberattack and requested clarification on the loan terms for affected practices.

Advocacy efforts to protect eye care patients in Kansas and Nebraska paid off with optometric scope of practice expansion bills in both states failing to receive votes before the close of their sessions.

Hundreds of ophthalmologists met with members of Congress and their staff last week to build and strengthen the relationships crucial to the Academy’s advocacy efforts, while introducing a new generation of eye surgeons to the important work of engaging on behalf of their patients and profession.

Our joint comments to the Centers for Medicare & Medicaid Services outlined our opposition to its proposal to pilot a new prior authorization requirement for ambulatory surgical centers (ASCs) delivering certain Medicare Part B services.

The Federal Trade Commission released a final rule this week that essentially bans using noncompete agreements for wide segments of the U.S. economy, with implications for small to very large ophthalmic practices.